Form: DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 30, 2008


EXHIBIT 10.1.1

 

SCHEDULE OF PARTIES TO ONCOGENEX VOTING AGREEMENTS

 

Each of the individuals identified below is party to a voting agreement with Sonus Pharmaceuticals, Inc. in the form filed as Exhibit 10.1 to Sonus’ Current Report on Form 8-K filed with the Securities and Exchange Commission on May 30, 2008:

 

Ventures West 7 Limited Partnership

Ventures West 7 U.S. Limited Partnership

H.I.G. Horizon Corp.

Working Opportunity Fund (EVCC) Ltd.

BDC Capital Inc.

Business Development Bank of Canada

Milestone Medica Corporation

Sherry Tryssenaar

Vancouver Prostate Research Foundation

Quest/BC Advantage Funds

WHI Morula Fund, LLC

Scott Cormack

Martin Gleave

603356 B.C. Ltd.

Steve Anderson

Cindy Jacobs

Neil Clendeninn

Tom Bailey